Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Internal Medicine Journal
|
July 25, 2022
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre
Constantine S Tam, Gareth P Gregory, Matthew Ku, et al.
Ejhaem
|
August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
Haematologica
|
February 23, 2023
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
Allison Barraclough, James T England, Diego Villa, et al.
Blood Advances
|
October 2, 2019
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance
Joshua W D Tobin, Gabrielle Rule, Katherine Colvin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
Tarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.
Biochemical Pharmacology
|
April 8, 2022
Obesity II: Establishing causal links between chemical exposures and obesity
Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Biochemical Pharmacology
|
June 17, 2022
Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015]
Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2024
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Michael Sargent Binkley, Jamie E Flerlage, Kerry J Savage, et al.
Blood Advances
|
April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses
Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Carcinogenesis
|
June 25, 2015
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
William H Goodson, Leroy Lowe, David O Carpenter, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Internal Medicine Journal
|
July 25, 2022
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre
Constantine S Tam, Gareth P Gregory, Matthew Ku, et al.
Ejhaem
|
August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
Haematologica
|
February 23, 2023
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
Allison Barraclough, James T England, Diego Villa, et al.
Blood Advances
|
October 2, 2019
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance
Joshua W D Tobin, Gabrielle Rule, Katherine Colvin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
Tarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.
Biochemical Pharmacology
|
April 8, 2022
Obesity II: Establishing causal links between chemical exposures and obesity
Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Biochemical Pharmacology
|
June 17, 2022
Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015]
Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2024
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Michael Sargent Binkley, Jamie E Flerlage, Kerry J Savage, et al.
Blood Advances
|
April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses
Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Carcinogenesis
|
June 25, 2015
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
William H Goodson, Leroy Lowe, David O Carpenter, et al.
Page
of 6